In this insightful KOL interview, we speak with Dr. Pavan SK, an experienced Uro-oncologist and Andrologist from Bengaluru, Karnataka, India, to explore contemporary approaches to benign prostatic hyperplasia (BPH) management in modern clinical practice. Dr. Pavan highlights evolving diagnostic pathways, patient stratification, and evidence-based t

We invite you to an insightful Live Webinar on Robotic-Assisted Kidney Transplantation (RAKT) with Dr Shafiq Ahmed, Senior Director, Uro-oncology and an expert in robotic kidney transplantation. Date- 30th January 2026 Time- 11:30 AM IST | 8:30 AM Cairo | 10:00 AM UAE | 2:00 PM SGT This session will highlight key clinical insights and evolving prac

Introduction Human papillomavirus (HPV) is a common sexually transmitted infection affecting men and women worldwide, yet it remains underrecognized as a men’s health concern (1). A 2023 systemic review shows a significant prevalence of HPV infection and disease in men (1). Nearly 31% of men aged 15 years and older are infected with at least one HP

Introduction Bladder cancer (BCa) remains a major global health concern, accounting for around 573,000 newly diagnosed cases and about 213,000 deaths in 2020, with men exhibiting nearly four times greater incidence and mortality rates compared to women (1). The disease predominantly affects older adults, as tumours of the bladder rarely occur befor

Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine. WHO Updates HIV Treatment and Prevention Guidance The World Health Organization has released updated HIV clinical guidelines, strengthening antiretroviral therapy recommendations, prevention of vertical transmission, and tuberculosis proph

Introduction Intrauterine growth restriction (IUGR) is a complex obstetric condition defined by the failure of a fetus to achieve its genetically predetermined growth potential (1). It is distinct from constitutionally small fetuses and is strongly associated with increased perinatal mortality, short-term neonatal morbidity, and long-term susceptib

Introduction Overactive bladder (OAB) is a symptom-defined lower urinary tract disorder that represents a substantial yet frequently underrecognized clinical burden (1). The International Continence Society defines OAB as urinary urgency, usually accompanied by increased daytime frequency and nocturia, with or without urgency urinary incontinence,

Introduction Overactive bladder (OAB) syndrome, as defined by the International Continence Society (ICS), is characterized by urinary urgency, with or without urgency urinary incontinence (UUI), usually accompanied by increased frequency and nocturia, in the absence of urinary tract infection (UTI) or other identifiable pathology (1). OAB is a high

Overactive bladder (OAB), as defined by the International Continence Society (ICS), is a symptom-based syndrome characterized by urinary urgency, with or without urgency urinary incontinence (UUI), usually accompanied by increased frequency and nocturia, in the absence of urinary tract infection or other identifiable pathology (1). This short case